DSEN Funding Decisions

The following links to CIHR's Funding Decision Database provide the decisions for the Drug Safety and Effectiveness Network's (DSEN) funding opportunities:

• Catalyst Grant: Post Market Drug Safety and Effectiveness 2009-10
• Team Grant: Drug Safety and Effectiveness Network Collaborating Centre for Prospective Studies 2011
  • Active Surveillance
  • Pharmacogenomics of adverse drug reaction
  • Comparative Effectiveness
• Team Grant: Network Meta-Analysis and Innovative RCT Designs 2011
  • Team Grant: DSEN Collaborating Centre - Network Meta-Analysis
  • Team Grant: DSEN Collaborating Centre - Innovative RCT Designs 2011
• New Investigator Salary Award: Fall 2011 Priority Announcement (Drug Safety and Effectiveness - Bayesian Statistics) [none approved]
• New Investigator Salary Award: Fall 2011 Priority Announcement (Drug Safety and Effectiveness - Drug Safety)
• New Investigator Salary Award: Fall 2011 Priority Announcement (Drug Safety and Effectiveness - Innovative RCT Designs) [none approved]
• New Investigator Salary Award: Fall 2011 Priority Announcement (Drug Safety and Effectiveness - Comparative Effectiveness)
• Operating Grant: Fall 2011 Priority Announcement (Drug Safety and Effectiveness - Innovative RCTs) [none approved]
• Operating Grant: Fall 2011 Priority Announcement (Drug Safety and Effectiveness - Bridge Funding)
• Rapid Funding for Drug Safety and Effectiveness Network (DSEN) Targeted Research 2012
• Catalyst Grant: Drug Safety & Effectiveness in Underrepresented Population 2012
• Rapid Funding for Drug Safety and Effectiveness Network (DSEN) Targeted Research
• DSEN Observational Studies